Etienne Riviere
Overview
Explore the profile of Etienne Riviere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riviere E, Horiot V, Tlili G, Mesguich C, Bletzung F, Blaison F, et al.
QJM
. 2025 Feb;
PMID: 39982389
No abstract available.
2.
Maillet F, Nguyen Y, Espitia O, Perard L, Salvarani C, Riviere E, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39898825
Objectives: To describe the characteristics and outcome of patients with the association of large vessel vasculitis (LVV, Takayasu arteritis [TA] or giant cell arteritis [GCA]) and inflammatory bowel disease (IBD)....
3.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood
. 2024 Oct;
145(2):244-247.
PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
4.
Riviere E, Nunes-Sanchez M, Haissaguerre M
Rev Med Interne
. 2024 Oct;
45(10):613-616.
PMID: 39415367
No abstract available.
5.
Durand P, Pottier V, Debordeaux F, Mesguich C, Duffau P, Lazaro E, et al.
Br J Haematol
. 2024 Oct;
206(1):279-289.
PMID: 39407432
In primary immune thrombocytopenia (ITP), predictors of disease evolution and treatment response are needed. Data based on the site of platelet destruction are scarce. We performed a retrospective single-centre study...
6.
Rauzy O, Bouillet L, Chevalier K, Cohen-Aubart F, Delacroix I, Hanslik T, et al.
Rev Med Interne
. 2024 Aug;
45(11):678-686.
PMID: 39142919
Rationale: On the occasion of the General stage meeting of Internal Medicine, the National College of Internal Medicine Teachers (CEMI) conducted a survey on teaching activity among all French university...
7.
Der Sahakian G, de Varenne M, Buleon C, Alinier G, Balmer C, Blanie A, et al.
Med Educ Online
. 2024 Jun;
29(1):2363006.
PMID: 38845343
Background: Simulation-based education in healthcare encompasses a wide array of modalities aimed at providing realistic clinical experiences supported by meticulously designed scenarios. The French-speaking Society for Simulation in Healthcare (SoFraSimS)...
8.
Papo M, Razanamahery J, Da Silva M, Helias-Rodzewicz Z, Potapenko V, Bota S, et al.
Haematologica
. 2024 May;
109(9):3048-3052.
PMID: 38779720
No abstract available.
9.
Riviere E
Br J Haematol
. 2024 Apr;
204(5):1573-1576.
PMID: 38600802
Asplenic patients are at high risk of serious infectious or thrombotic complications, especially when they are not adequately informed of the risk and not closely followed. Ladhani et al. on...
10.
Riviere E, Jourde W, Gensous N, Demant X, Ribeiro E, Duffau P, et al.
Respir Res
. 2024 Mar;
25(1):124.
PMID: 38486260
Background: Infliximab is currently recommended as a third-line treatment for refractory sarcoidosis. Data in function of clinical phenotype are currently lacking. We evaluated patients' characteristics and responses to infliximab according...